CHRISTINE HARMS: Open Payments
NPI 1104900646 · CORPUS CHRISTI, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,169 in 73 payments from 15 companies in 2025. Trend: 2023 $1,710 · 2024 $1,518 · 2025 $1,169
Food & beverage: $1,162Education: $7
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $290 |
| Lilly USA, LLC | 17 | $219 |
| Amgen Inc. | 15 | $201 |
| Merck Sharp & Dohme LLC | 4 | $104 |
| SANOFI PASTEUR INC. | 3 | $64 |
| Dexcom, Inc. | 3 | $52 |
| Corcept Therapeutics | 2 | $41 |
| Kowa Pharmaceuticals America, Inc. | 2 | $37 |
| Phathom Pharmaceuticals, Inc. | 2 | $34 |
| GlaxoSmithKline, LLC. | 2 | $30 |
Products named: Ozempic, MOUNJARO, OTEZLA, CAPVAXIVE, Wegovy, FLUZONE HIGH-DOSE, EVENITY, Dexcom G6 Transmitter.
Industry payments across TX — which companies pay providers there.
